UY30352A1 - Nuevas prolinamidas sustituidas, composiciones conteniéndolas, procesos de preparacion y aplicaciones - Google Patents

Nuevas prolinamidas sustituidas, composiciones conteniéndolas, procesos de preparacion y aplicaciones

Info

Publication number
UY30352A1
UY30352A1 UY30352A UY30352A UY30352A1 UY 30352 A1 UY30352 A1 UY 30352A1 UY 30352 A UY30352 A UY 30352A UY 30352 A UY30352 A UY 30352A UY 30352 A1 UY30352 A1 UY 30352A1
Authority
UY
Uruguay
Prior art keywords
new
prolined
substitutes
applications
compositions containing
Prior art date
Application number
UY30352A
Other languages
English (en)
Spanish (es)
Inventor
Annette Schuler-Metz
Henning Priepke
Roland Pfau
Hebert Nar
Georg Dahmann
Wolfgang Wienen
Kai Gerlach
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of UY30352A1 publication Critical patent/UY30352A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
UY30352A 2006-05-16 2007-05-15 Nuevas prolinamidas sustituidas, composiciones conteniéndolas, procesos de preparacion y aplicaciones UY30352A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06113977 2006-05-16
EP07102566 2007-02-16

Publications (1)

Publication Number Publication Date
UY30352A1 true UY30352A1 (es) 2008-01-02

Family

ID=38646563

Family Applications (1)

Application Number Title Priority Date Filing Date
UY30352A UY30352A1 (es) 2006-05-16 2007-05-15 Nuevas prolinamidas sustituidas, composiciones conteniéndolas, procesos de preparacion y aplicaciones

Country Status (23)

Country Link
US (1) US7807693B2 (cg-RX-API-DMAC7.html)
EP (1) EP2051975B1 (cg-RX-API-DMAC7.html)
JP (1) JP5263686B2 (cg-RX-API-DMAC7.html)
KR (1) KR101422456B1 (cg-RX-API-DMAC7.html)
AR (1) AR060945A1 (cg-RX-API-DMAC7.html)
AU (1) AU2007251614B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0711648A2 (cg-RX-API-DMAC7.html)
CA (1) CA2653753C (cg-RX-API-DMAC7.html)
CL (1) CL2007001391A1 (cg-RX-API-DMAC7.html)
DK (1) DK2051975T3 (cg-RX-API-DMAC7.html)
EA (1) EA200802210A1 (cg-RX-API-DMAC7.html)
EC (1) ECSP088824A (cg-RX-API-DMAC7.html)
ES (1) ES2395538T3 (cg-RX-API-DMAC7.html)
IL (1) IL195245A (cg-RX-API-DMAC7.html)
MX (1) MX2008014499A (cg-RX-API-DMAC7.html)
MY (1) MY146623A (cg-RX-API-DMAC7.html)
NO (1) NO20084530L (cg-RX-API-DMAC7.html)
NZ (1) NZ573573A (cg-RX-API-DMAC7.html)
PE (1) PE20080702A1 (cg-RX-API-DMAC7.html)
PL (1) PL2051975T3 (cg-RX-API-DMAC7.html)
TW (1) TW200813047A (cg-RX-API-DMAC7.html)
UY (1) UY30352A1 (cg-RX-API-DMAC7.html)
WO (1) WO2007131982A2 (cg-RX-API-DMAC7.html)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1975165A1 (de) 2007-03-27 2008-10-01 Boehringer Ingelheim Pharma GmbH & Co. KG Substituierte Pyrrolidinamide, deren Herstellung und deren Verwendung als Arzneimittel
WO2009063028A2 (en) 2007-11-15 2009-05-22 Boehringer Ingelheim International Gmbh Substituted amides, manufacturing and use thereof as medicaments
US20110046130A1 (en) * 2008-03-31 2011-02-24 Evotec Ag Tetrahydronaphthyridines and aza derivatives thereof as histamine h3 receptor antagonists
GB201209138D0 (en) * 2012-05-24 2012-07-04 Ono Pharmaceutical Co Compounds
EP2958919B1 (en) 2013-02-21 2019-05-22 Boehringer Ingelheim International GmbH Dihydropteridinones i
JP6337750B2 (ja) * 2013-11-22 2018-06-06 小野薬品工業株式会社 化合物
DK3102576T3 (da) 2014-02-03 2019-07-22 Vitae Pharmaceuticals Llc Dihydropyrrolopyridininhibitorer af ror-gamma
HRP20221373T1 (hr) * 2014-03-07 2023-01-06 Biocryst Pharmaceuticals, Inc. Supstituirani pirazoli kao inhibitori kalikreina u ljudskoj plazmi
SI3207043T1 (sl) 2014-10-14 2019-04-30 Vitae Pharmaceuticals, Inc. Dihidropirolopiridinovi inhibitorji za ROR-gama
US9845308B2 (en) 2014-11-05 2017-12-19 Vitae Pharmaceuticals, Inc. Isoindoline inhibitors of ROR-gamma
US9663515B2 (en) 2014-11-05 2017-05-30 Vitae Pharmaceuticals, Inc. Dihydropyrrolopyridine inhibitors of ROR-gamma
EP3078378B1 (en) 2015-04-08 2020-06-24 Vaiomer Use of factor xa inhibitors for regulating glycemia
EP3331876B1 (en) 2015-08-05 2020-10-07 Vitae Pharmaceuticals, LLC Modulators of ror-gamma
EP3868750A1 (en) 2015-11-20 2021-08-25 Vitae Pharmaceuticals, LLC Modulators of ror-gamma
TWI757266B (zh) 2016-01-29 2022-03-11 美商維它藥物有限責任公司 ROR-γ調節劑
US9481674B1 (en) 2016-06-10 2016-11-01 Vitae Pharmaceuticals, Inc. Dihydropyrrolopyridine inhibitors of ROR-gamma
CN115716826A (zh) 2017-07-24 2023-02-28 生命医药有限责任公司 RORγ的抑制剂
WO2019018975A1 (en) 2017-07-24 2019-01-31 Vitae Pharmaceuticals, Inc. INHIBITORS OF ROR GAMMA
CN114646701B (zh) * 2022-03-01 2023-09-29 浙江国邦药业有限公司 一种l-脯氨酰胺中有关物质的hplc测试方法
CN121311466A (zh) * 2023-04-14 2026-01-09 辉瑞大药厂 葡萄糖依赖性促胰岛素多肽受体拮抗剂及其用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7030141B2 (en) 2001-11-29 2006-04-18 Christopher Franklin Bigge Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade
JP3975254B2 (ja) * 2002-07-25 2007-09-12 日野自動車株式会社 チャイルドシート用アンカの取付構造
PL377633A1 (pl) 2003-04-03 2006-02-06 Merck Patent Gmbh Związki karbonylowe
DE10329457A1 (de) * 2003-04-03 2005-01-20 Merck Patent Gmbh Ethinylprolinderivate
US7557222B2 (en) * 2003-06-18 2009-07-07 Merck Patent Gmbh 1-[(4-Ethynylphenyl)]-2-[(phenyl)]-pyrrolidine-1,2-dicarboxamide derivatives as inhibitors of coagulation factors Xa and VIIa for the treatment of thrombosis
ES2223277B1 (es) 2003-06-19 2006-03-01 Fernando Bouffard Fita Composicion anestesica para administracion topica.
DE10358814A1 (de) * 2003-12-16 2005-07-21 Merck Patent Gmbh Prolinylarylacetamide
DE102004014945A1 (de) 2004-03-26 2005-10-13 Merck Patent Gmbh Prolinylderivate
US7453002B2 (en) * 2004-06-15 2008-11-18 Bristol-Myers Squibb Company Five-membered heterocycles useful as serine protease inhibitors
DE102004045796A1 (de) 2004-09-22 2006-03-23 Merck Patent Gmbh Arzneimittel enthaltend Carbonylverbindungen sowie deren Verwendung
EP1869010A1 (en) 2005-04-11 2007-12-26 Glaxo Group Limited 3-sulfonylamino-pyrrolidine-2-one derivatives as factor xa inhibitors
AU2006271781A1 (en) * 2005-07-15 2007-01-25 F. Hoffmann-La Roche Ag Novel heteroaryl fused cyclic amines

Also Published As

Publication number Publication date
CA2653753C (en) 2013-09-24
PE20080702A1 (es) 2008-07-10
IL195245A (en) 2012-09-24
AU2007251614B2 (en) 2013-01-17
DK2051975T3 (da) 2012-10-15
JP5263686B2 (ja) 2013-08-14
WO2007131982A2 (de) 2007-11-22
US20080139605A1 (en) 2008-06-12
MY146623A (en) 2012-09-14
AU2007251614A1 (en) 2007-11-22
AR060945A1 (es) 2008-07-23
EP2051975B1 (de) 2012-09-12
EP2051975A2 (de) 2009-04-29
US7807693B2 (en) 2010-10-05
TW200813047A (en) 2008-03-16
KR101422456B1 (ko) 2014-07-23
CA2653753A1 (en) 2007-11-22
HK1131140A1 (en) 2010-01-15
CL2007001391A1 (es) 2008-01-18
PL2051975T3 (pl) 2013-01-31
KR20090017523A (ko) 2009-02-18
MX2008014499A (es) 2008-11-27
WO2007131982A3 (de) 2008-01-10
ECSP088824A (es) 2008-11-27
IL195245A0 (en) 2009-09-22
ES2395538T3 (es) 2013-02-13
NZ573573A (en) 2011-10-28
BRPI0711648A2 (pt) 2011-11-29
NO20084530L (no) 2008-12-12
JP2009537483A (ja) 2009-10-29
EA200802210A1 (ru) 2009-06-30

Similar Documents

Publication Publication Date Title
UY30979A1 (es) Pirrolidinamidas sustituidas, su preparacion y su uso como medicamentos
ECSP088824A (es) Prolinamidas sustituidas, su preparación y su uso como medicamentos
ECSP078058A (es) Nuevas glicinamidas sustituidas, su preparación y su uso como medicamentos
ECSP12012161A (es) Compuestos en calidad de antagonistas de Bradiquinina-b1
ATE548374T1 (de) 2'-fluor-2'-desoxytetrahydrouridine als cytidindeaminaseinhibitoren
UY28773A1 (es) Nuevas amidas de ácidos carboxílicos, su preparación y su uso como medicamentos.
ECSP10010599A (es) Derivados de tienopiridonas como activadores de proteina quinasa activados por amp (ampk)
CR11370A (es) Inhibidores de quinasas simil polo
GT200800170A (es) Compuestos de n-formil-hidroxilamina
CO6280399A2 (es) Peptidil nitrilos y uso de los mismos como inhibidores de peptidil peptidasa i
ATE522518T1 (de) Indazol- und isoindolderivate als glucokinaseaktivierende stoffe
ECSP10010722A (es) Compuestos orgánicos
ECSP109978A (es) Nuevos compuestos
ECSP10010654A (es) Derivados de tienopiridonas como activadores de proteína quinasa activados por amp (ampk)
ECSP066898A (es) Antagonistas de cgrp seleccionados, procedimiento para su preparación así como su uso como medicamento
UY32098A (es) Heteroarilos sustituidos
PA8855001A1 (es) Monocarbamas
CR20110381A (es) Antagonistas de 4-azetidinil-1-heteroaril-ciclohexanol de ccr2
GT200600174A (es) Pirrolopiridinas sustituidas, composiciones que las contienen, proceso de fabricacion y utilizacion
CR11273A (es) Derivados-2-ona disustituidos en 3, su preparacion y su aplicacion en terapeutica
GT200500292A (es) Derivados de 2-amido-4-feniltiazol, su preparacion y su aplicacion en terapeutica
UY28848A1 (es) Antagonistas de cgrp seleccionados, procedimientos para su preparación, y su empleo como medicamentos
DE602007013077D1 (de) Organische verbindungen
DE602007008691D1 (de) Cyclische sulfone, die zur verwendung als bace-inhibitoren geeignet sind
UY31286A1 (es) Antagonistas de receptores de bradiquinina b1. proceso de preparación y aplicaciones.

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20170609